At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 200 enrolled
Drug / intervention
Ferrous Sulfate +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of the Effects of Enteral Iron Supplementation on Anemia and Risk of Infection in Critical Illness
In Brief
A Phase 2 clinical trial evaluating Ferrous Sulfate and Placebo Oral Tablet for Anemic, Critically Ill Patients. Completed, enrolled 200 participants across 1 site.
Detailed Summary
The purpose of this study is to investigate the efficacy of enteral iron supplementation for improving anemia, decreasing the risk of blood transfusion, and decreasing mortality in patients who are hospitalized in the intensive care unit. This study will also address any relationship between enteral iron supplementation and risk of infection.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnemic, Critically Ill Patients
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 2006
First PostedMar 2007
Primary CompletionDec 2007
Study CompletionJan 2008
TodayJul 2026
First PostedMar 21, 2007
Enrollment StartJan 1, 2006
Primary CompletionDec 1, 2007
Study CompletionJan 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 19.3 years ago
Interventions
Ferrous Sulfatedrug
Iron group
Placebo Oral Tabletdrug
Placebo group